List of insiders holdings for CytomX Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2024-02-14 10:09:53 | 6,702,889 0 | 6,702,889 | Form 13G |
| SHANNON TIMOTHY M Director | 2016-12-01 14:35:01 | 448 3,244,381 | 3,244,829 | Form 4 |
| Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Possible Member of 10% Group 10% Owner | 2015-10-14 12:37:56 | 946,024 0 | 946,024 | Form 13G |
| Hadley Harbor Master Investors (Cayman) L.P. 10% Owner | 2015-10-14 15:36:21 | 749,055 0 | 749,055 | Form 4 |
| McCarthy Sean A. CEO | 2024-03-28 19:12:49 | 634,249 93,158 | 727,407 | Form 4 |
| Goeltz II Robert C. Chief Financial Officer | 2017-05-16 16:57:43 | 323,325 0 | 323,325 | Form 4 |
| THIRD ROCK VENTURES LP Third Rock Ventures GP L.P. TRV GP LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner | 2019-02-13 16:07:03 | 227,653 0 | 227,653 | Form 13G |
| Chu Yu-Waye Chief Medical Officer | 2024-01-19 20:37:27 | 223,750 0 | 223,750 | Form 4 |
| BELVIN MARCIA SVP, Chief Scientific Officer | 2024-03-21 16:37:36 | 168,579 0 | 168,579 | Form 4 |
| Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | 2020-02-19 18:41:18 | 120,000 0 | 120,000 | Form 4 |
| Landau Jeffrey B Chief Business Officer | 2024-03-21 16:36:46 | 110,060 7680 | 117,740 | Form 4 |
| ROWLAND LLOYD A General Counsel | 2024-03-21 16:41:27 | 117,728 0 | 117,728 | Form 4 |
| RAY DEBANJAN Chief Financial Officer | 2019-01-29 18:57:09 | 90,000 0 | 90,000 | Form 4 |
| HUMPHREY RACHEL Chief Medical Officer | 2019-01-29 19:00:03 | 90,000 0 | 90,000 | Form 4 |
| Ogden Christopher SVP, Finance and Accounting | 2024-03-21 16:38:57 | 85,686 0 | 85,686 | Form 4 |
| LADD CYNTHIA J Senior VP and General Counsel | 2017-01-27 13:52:15 | 84,000 0 | 84,000 | Form 4 |
| Su Zhen Director | 2024-03-22 16:27:39 | 76,000 0 | 76,000 | Form 4 |
| Peterson Amy C. EVP, Chief Development Officer | 2023-03-20 18:43:26 | 58,433 0 | 58,433 | Form 4 |
| Campoy Carlos Chief Financial Officer | 2023-03-20 18:43:33 | 38,224 0 | 38,224 | Form 4 |
| Knifsend Robin Principal Accounting Officer | 2020-02-21 12:34:43 | 34,000 0 | 34,000 | Form 4 |
| HANNAH ALISON L. Chief Medical Officer | 2022-07-21 16:09:25 | 31,898 0 | 31,898 | Form 4 |
| GLUCK FREDERICK W Director | 2022-06-17 16:05:38 | 25,000 0 | 25,000 | Form 4 |
| Jones Elaine V Director | 2023-06-16 17:49:16 | 25,000 0 | 25,000 | Form 4 |
| Gilbert Halley E Director | 2023-06-16 17:49:55 | 25,000 0 | 25,000 | Form 4 |
| Ashworth Alan Director | 2023-06-16 17:50:50 | 25,000 0 | 25,000 | Form 4 |
| Young Matthew P. Director | 2023-06-16 17:51:46 | 25,000 0 | 25,000 | Form 4 |
| Mohindru Mani Director | 2023-06-16 17:52:58 | 25,000 0 | 25,000 | Form 4 |
| Meyers James R Director | 2023-06-16 17:54:26 | 25,000 0 | 25,000 | Form 4 |
| SCARLETT JOHN A Director | 2021-06-17 18:46:39 | 20,000 0 | 20,000 | Form 4 |
| Fuchs Charles S. Director | 2020-06-17 17:06:48 | 20,000 0 | 20,000 | Form 4 |
| Huh Hoyoung Director | 2018-06-15 17:51:36 | 14,000 0 | 14,000 | Form 4 |
| McCourt Marion Director | 2017-06-22 13:58:17 | 14,000 0 | 14,000 | Form 4 |
| Exter Neil Director | 2017-06-22 13:56:58 | 14,000 0 | 14,000 | Form 4 |
| Canaan IX L.P. Canaan Partners IX LLC Director | 2017-07-07 08:40:32 | 0 0 | 0 | Form 13G |